

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 5.96139573 |
| 2 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.55190231 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.28576461 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 5.08450572 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02261544 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96713797 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.91700675 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.56220800 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.55449882 |
| 10 | regulation of germinal center formation (GO:0002634) | 4.46209741 |
| 11 | regulation of B cell differentiation (GO:0045577) | 4.38445669 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.32202498 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.32202498 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.32202498 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.32202498 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.32202498 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.32202498 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.29812163 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.29373234 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.26896504 |
| 21 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.23422592 |
| 22 | neutrophil activation (GO:0042119) | 4.19141129 |
| 23 | cellular response to zinc ion (GO:0071294) | 4.17654996 |
| 24 | B cell proliferation (GO:0042100) | 4.13871970 |
| 25 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.11315856 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 4.02489222 |
| 27 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.00221227 |
| 28 | granulocyte activation (GO:0036230) | 3.98724240 |
| 29 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98146003 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.97162678 |
| 31 | negative regulation of B cell apoptotic process (GO:0002903) | 3.93249614 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.88690517 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.88690517 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.88607505 |
| 35 | defense response to protozoan (GO:0042832) | 3.84684247 |
| 36 | natural killer cell differentiation (GO:0001779) | 3.83176333 |
| 37 | positive regulation of protein homooligomerization (GO:0032464) | 3.80342866 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.69922627 |
| 39 | mature B cell differentiation involved in immune response (GO:0002313) | 3.69556259 |
| 40 | respiratory burst (GO:0045730) | 3.66032527 |
| 41 | regulation of B cell apoptotic process (GO:0002902) | 3.65524912 |
| 42 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.64974277 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.63819538 |
| 44 | negative regulation of B cell proliferation (GO:0030889) | 3.63560948 |
| 45 | positive regulation of interleukin-12 production (GO:0032735) | 3.62049489 |
| 46 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.56049762 |
| 47 | natural killer cell mediated immunity (GO:0002228) | 3.56049762 |
| 48 | detection of bacterium (GO:0016045) | 3.54352409 |
| 49 | myeloid dendritic cell activation (GO:0001773) | 3.52739444 |
| 50 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.50521028 |
| 51 | myeloid dendritic cell differentiation (GO:0043011) | 3.49815742 |
| 52 | T cell lineage commitment (GO:0002360) | 3.47312433 |
| 53 | T cell costimulation (GO:0031295) | 3.46652194 |
| 54 | serine transport (GO:0032329) | 3.44269787 |
| 55 | lymphocyte costimulation (GO:0031294) | 3.41620996 |
| 56 | T-helper 1 type immune response (GO:0042088) | 3.39676190 |
| 57 | cellular response to interferon-gamma (GO:0071346) | 3.39128963 |
| 58 | cytidine metabolic process (GO:0046087) | 3.38874594 |
| 59 | cytidine catabolic process (GO:0006216) | 3.38874594 |
| 60 | cytidine deamination (GO:0009972) | 3.38874594 |
| 61 | response to protozoan (GO:0001562) | 3.38419448 |
| 62 | germinal center formation (GO:0002467) | 3.37352033 |
| 63 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.34679074 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.34044490 |
| 65 | regulation of B cell proliferation (GO:0030888) | 3.33788082 |
| 66 | negative T cell selection (GO:0043383) | 3.33425762 |
| 67 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.32760607 |
| 68 | response to type I interferon (GO:0034340) | 3.30959507 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.30348765 |
| 70 | B cell mediated immunity (GO:0019724) | 3.29955750 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27875956 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.27409880 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.27409880 |
| 74 | mature B cell differentiation (GO:0002335) | 3.26540207 |
| 75 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.25844806 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25607824 |
| 77 | positive T cell selection (GO:0043368) | 3.24739406 |
| 78 | detection of other organism (GO:0098543) | 3.21712497 |
| 79 | response to peptidoglycan (GO:0032494) | 3.21616153 |
| 80 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.19903811 |
| 81 | dendritic cell chemotaxis (GO:0002407) | 3.19872337 |
| 82 | B cell homeostasis (GO:0001782) | 3.19498668 |
| 83 | regulation of B cell activation (GO:0050864) | 3.19406214 |
| 84 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.18778851 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16795373 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16452246 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 3.15370491 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 3.13016887 |
| 89 | hepatocyte apoptotic process (GO:0097284) | 3.12721189 |
| 90 | thymic T cell selection (GO:0045061) | 3.12492897 |
| 91 | mast cell activation (GO:0045576) | 3.11520227 |
| 92 | regulation of activation of Janus kinase activity (GO:0010533) | 3.10863402 |
| 93 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.10337595 |
| 94 | negative regulation of interleukin-17 production (GO:0032700) | 3.09760183 |
| 95 | * B cell activation (GO:0042113) | 3.09429234 |
| 96 | positive regulation of protein oligomerization (GO:0032461) | 3.07360080 |
| 97 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04379520 |
| 98 | histamine secretion (GO:0001821) | 3.02996698 |
| 99 | cellular extravasation (GO:0045123) | 3.02719397 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.01072050 |
| 101 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.99314982 |
| 102 | natural killer cell activation (GO:0030101) | 2.98930734 |
| 103 | positive regulation of type 2 immune response (GO:0002830) | 2.98796540 |
| 104 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97940323 |
| 105 | positive regulation of B cell activation (GO:0050871) | 2.97840892 |
| 106 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97769479 |
| 107 | T cell migration (GO:0072678) | 2.97357933 |
| 108 | positive regulation of interferon-beta production (GO:0032728) | 2.97356633 |
| 109 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.96291934 |
| 110 | regulation of thymocyte apoptotic process (GO:0070243) | 2.95433782 |
| 111 | T cell selection (GO:0045058) | 2.94349930 |
| 112 | positive regulation of macrophage cytokine production (GO:0060907) | 2.94163054 |
| 113 | response to host immune response (GO:0052572) | 2.94119419 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94119419 |
| 115 | response to interferon-gamma (GO:0034341) | 2.93706500 |
| 116 | L-serine transport (GO:0015825) | 2.92681243 |
| 117 | mononuclear cell proliferation (GO:0032943) | 2.92670592 |
| 118 | positive regulation of neutrophil migration (GO:1902624) | 2.92515305 |
| 119 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.92515305 |
| 120 | myeloid leukocyte activation (GO:0002274) | 2.92281779 |
| 121 | lymphocyte proliferation (GO:0046651) | 2.91907336 |
| 122 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91261518 |
| 123 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.91211340 |
| 124 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.89843453 |
| 125 | dendritic cell migration (GO:0036336) | 2.89139697 |
| 126 | dendritic cell differentiation (GO:0097028) | 2.88765306 |
| 127 | regulation of interleukin-12 production (GO:0032655) | 2.88211432 |
| 128 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.88089446 |
| 129 | regulation of RIG-I signaling pathway (GO:0039535) | 2.87256749 |
| 130 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.85084746 |
| 131 | response to muramyl dipeptide (GO:0032495) | 2.84643725 |
| 132 | positive regulation of B cell proliferation (GO:0030890) | 2.84624602 |
| 133 | lymphocyte homeostasis (GO:0002260) | 2.84226239 |
| 134 | adaptive immune response (GO:0002250) | 2.82471717 |
| 135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.82459985 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.81285989 |
| 137 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.81207710 |
| 138 | T cell homeostasis (GO:0043029) | 2.81099625 |
| 139 | Peyers patch development (GO:0048541) | 2.80413979 |
| 140 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.80413979 |
| 141 | macrophage activation (GO:0042116) | 2.80397099 |
| 142 | positive regulation of interferon-gamma production (GO:0032729) | 2.80368352 |
| 143 | cellular response to interferon-beta (GO:0035458) | 2.79117099 |
| 144 | leukocyte homeostasis (GO:0001776) | 2.79017404 |
| 145 | negative regulation of bone resorption (GO:0045779) | 2.78573065 |
| 146 | mast cell activation involved in immune response (GO:0002279) | 2.78232070 |
| 147 | mast cell degranulation (GO:0043303) | 2.78232070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.08341623 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.96385087 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.18716304 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.74184936 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.23402602 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.94826288 |
| 7 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.93493233 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.69861686 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66919808 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40824345 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35124330 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32859272 |
| 13 | * MYC_22102868_ChIP-Seq_BL_Human | 3.16646863 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06344032 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.74363532 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63238117 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46821553 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45132647 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44847620 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.41747865 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34004013 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.27129981 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25494703 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24041929 |
| 25 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23045706 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20997730 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20885117 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.20334438 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20275228 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20028376 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19090422 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15473861 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10339912 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00598640 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96691490 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96372703 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88339999 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88335631 |
| 39 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.83220803 |
| 40 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77436934 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.71811568 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69868461 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58268518 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57106241 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50587408 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49621921 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45031076 |
| 48 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42625477 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42318271 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41449152 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40297624 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33198565 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32657949 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.31829590 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28002524 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.25746735 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24746695 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23023727 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20315451 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20168987 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17692864 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16605250 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16035513 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15704590 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15162792 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12450255 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08868858 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08140174 |
| 69 | * P300_27268052_Chip-Seq_Bcells_Human | 1.08117966 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06939739 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06113238 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05320731 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03914673 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02794329 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01042353 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00511740 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00283709 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98933550 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97749749 |
| 80 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96356491 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96173319 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95998906 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95104543 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93784426 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93313425 |
| 86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92093121 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89546801 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89249646 |
| 89 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89105956 |
| 90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88997205 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.88933835 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88304786 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87844530 |
| 94 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86999228 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85190461 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84611645 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84005570 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83043936 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82340977 |
| 100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82125795 |
| 101 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.80669587 |
| 102 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80424492 |
| 103 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79265543 |
| 104 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79254803 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79154795 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.78834714 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77188913 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77031192 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76042399 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74510502 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74286426 |
| 112 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.73263308 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72664273 |
| 114 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.69945104 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69886567 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.69234276 |
| 117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.69065601 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68530495 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.67859080 |
| 120 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65379009 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63964292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.42473009 |
| 2 | MP0000685_abnormal_immune_system | 3.98928742 |
| 3 | * MP0001800_abnormal_humoral_immune | 3.95586056 |
| 4 | MP0001790_abnormal_immune_system | 3.87678322 |
| 5 | MP0005387_immune_system_phenotype | 3.87678322 |
| 6 | * MP0002452_abnormal_antigen_presenting | 3.39172293 |
| 7 | MP0005671_abnormal_response_to | 3.25642095 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.15622441 |
| 9 | MP0009785_altered_susceptibility_to | 3.08749390 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.00188955 |
| 11 | * MP0002723_abnormal_immune_serum | 2.99526170 |
| 12 | MP0003303_peritoneal_inflammation | 2.94444121 |
| 13 | MP0003436_decreased_susceptibility_to | 2.82142168 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.76519879 |
| 15 | * MP0001819_abnormal_immune_cell | 2.75697518 |
| 16 | MP0005025_abnormal_response_to | 2.61917120 |
| 17 | MP0002419_abnormal_innate_immunity | 2.49512467 |
| 18 | MP0006082_CNS_inflammation | 2.47172587 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.44401752 |
| 20 | * MP0000716_abnormal_immune_system | 2.33953285 |
| 21 | MP0005310_abnormal_salivary_gland | 2.17236927 |
| 22 | * MP0000689_abnormal_spleen_morphology | 2.13895284 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.05271963 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.90088858 |
| 25 | * MP0002722_abnormal_immune_system | 1.87491554 |
| 26 | * MP0002429_abnormal_blood_cell | 1.87071393 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.87038377 |
| 28 | MP0004947_skin_inflammation | 1.86647724 |
| 29 | MP0002405_respiratory_system_inflammati | 1.82894915 |
| 30 | MP0004510_myositis | 1.80650102 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.79772201 |
| 32 | MP0001853_heart_inflammation | 1.74626273 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.74256288 |
| 34 | MP0002006_tumorigenesis | 1.71000001 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.64031469 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.60809752 |
| 37 | MP0001873_stomach_inflammation | 1.53974679 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.47631438 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.46079324 |
| 40 | MP0003646_muscle_fatigue | 1.45521844 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.45512680 |
| 42 | MP0005451_abnormal_body_composition | 1.43952043 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.43286742 |
| 44 | MP0008057_abnormal_DNA_replication | 1.40899265 |
| 45 | MP0003252_abnormal_bile_duct | 1.40054782 |
| 46 | MP0009278_abnormal_bone_marrow | 1.36587189 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.34056248 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.30212780 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.26642661 |
| 50 | MP0002132_abnormal_respiratory_system | 1.26641128 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.25653061 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.25337154 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.23727821 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.22628998 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.20715686 |
| 56 | MP0008469_abnormal_protein_level | 1.17852394 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.16559740 |
| 58 | MP0002254_reproductive_system_inflammat | 1.16346007 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.13056423 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.13056423 |
| 61 | MP0002009_preneoplasia | 1.10049211 |
| 62 | MP0003724_increased_susceptibility_to | 1.08043590 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.06400786 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.04612779 |
| 65 | MP0009697_abnormal_copulation | 1.03021521 |
| 66 | MP0003866_abnormal_defecation | 1.02757682 |
| 67 | MP0000490_abnormal_crypts_of | 1.02626161 |
| 68 | MP0009764_decreased_sensitivity_to | 1.01941227 |
| 69 | MP0010307_abnormal_tumor_latency | 1.01026585 |
| 70 | MP0008007_abnormal_cellular_replicative | 0.97864158 |
| 71 | MP0003448_altered_tumor_morphology | 0.95363571 |
| 72 | * MP0002019_abnormal_tumor_incidence | 0.93600541 |
| 73 | MP0005360_urolithiasis | 0.93148536 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.92966722 |
| 75 | MP0010094_abnormal_chromosome_stability | 0.91265719 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.90217511 |
| 77 | MP0002933_joint_inflammation | 0.88444537 |
| 78 | MP0005166_decreased_susceptibility_to | 0.87915249 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.87235351 |
| 80 | MP0008872_abnormal_physiological_respon | 0.86246463 |
| 81 | MP0000858_altered_metastatic_potential | 0.85877878 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.84172990 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.82760485 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.82558845 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.82353188 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.81401398 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.81269717 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.79787096 |
| 89 | MP0003091_abnormal_cell_migration | 0.78843008 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.78198307 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 0.77214779 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.75832790 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.74018869 |
| 94 | MP0006054_spinal_hemorrhage | 0.73509940 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.70115638 |
| 96 | MP0003077_abnormal_cell_cycle | 0.69368360 |
| 97 | MP0002163_abnormal_gland_morphology | 0.68560130 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.68072167 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.66384713 |
| 100 | MP0003828_pulmonary_edema | 0.65918699 |
| 101 | MP0008058_abnormal_DNA_repair | 0.64641039 |
| 102 | MP0009643_abnormal_urine_homeostasis | 0.64050420 |
| 103 | MP0001666_abnormal_nutrient_absorption | 0.63156824 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.62097096 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.61781910 |
| 106 | MP0003045_fibrosis | 0.60844683 |
| 107 | MP0001346_abnormal_lacrimal_gland | 0.59287682 |
| 108 | MP0003690_abnormal_glial_cell | 0.59153863 |
| 109 | MP0003075_altered_response_to | 0.58988665 |
| 110 | MP0002928_abnormal_bile_duct | 0.58093000 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.57385651 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.56487130 |
| 113 | MP0000371_diluted_coat_color | 0.55864540 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55687873 |
| 115 | MP0004883_abnormal_blood_vessel | 0.55529862 |
| 116 | MP0009763_increased_sensitivity_to | 0.55329305 |
| 117 | MP0000609_abnormal_liver_physiology | 0.54667471 |
| 118 | MP0001663_abnormal_digestive_system | 0.54139150 |
| 119 | MP0001915_intracranial_hemorrhage | 0.54090428 |
| 120 | MP0001764_abnormal_homeostasis | 0.53517966 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.52394947 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.52305301 |
| 123 | MP0000249_abnormal_blood_vessel | 0.52262809 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.51885568 |
| 125 | MP0004147_increased_porphyrin_level | 0.51821106 |
| 126 | MP0009840_abnormal_foam_cell | 0.51224014 |
| 127 | MP0000313_abnormal_cell_death | 0.50480125 |
| 128 | MP0003868_abnormal_feces_composition | 0.48406984 |
| 129 | MP0000372_irregular_coat_pigmentation | 0.47996328 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.45927329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Agammaglobulinemia (HP:0004432) | 8.79486439 |
| 2 | * Cellulitis (HP:0100658) | 6.91990322 |
| 3 | * Verrucae (HP:0200043) | 5.29560714 |
| 4 | * Papilloma (HP:0012740) | 5.29560714 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.13081171 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.99927287 |
| 7 | Recurrent viral infections (HP:0004429) | 4.87923743 |
| 8 | * Meningitis (HP:0001287) | 4.61414956 |
| 9 | Colitis (HP:0002583) | 4.55465439 |
| 10 | * Osteomyelitis (HP:0002754) | 4.54374266 |
| 11 | * Recurrent pneumonia (HP:0006532) | 4.53773685 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.50052347 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.48138136 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 4.23706455 |
| 15 | Abnormality of B cell number (HP:0010975) | 4.16590630 |
| 16 | B lymphocytopenia (HP:0010976) | 4.16590630 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.13550505 |
| 18 | Thyroiditis (HP:0100646) | 4.07642238 |
| 19 | Inflammation of the large intestine (HP:0002037) | 4.07448874 |
| 20 | Recurrent fungal infections (HP:0002841) | 4.04582144 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 3.96516762 |
| 22 | * Recurrent lower respiratory tract infections (HP:0002783) | 3.95821279 |
| 23 | Recurrent sinusitis (HP:0011108) | 3.84664444 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.83122938 |
| 25 | * Sepsis (HP:0100806) | 3.78435631 |
| 26 | Vasculitis (HP:0002633) | 3.71704511 |
| 27 | IgM deficiency (HP:0002850) | 3.62701827 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.56970570 |
| 29 | Small epiphyses (HP:0010585) | 3.52482960 |
| 30 | Recurrent skin infections (HP:0001581) | 3.47158171 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 3.44416073 |
| 32 | Chronic otitis media (HP:0000389) | 3.39286946 |
| 33 | Abnormality of the prostate (HP:0008775) | 3.38372152 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.36318183 |
| 35 | Lymphopenia (HP:0001888) | 3.35401147 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32014770 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32014770 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26631530 |
| 39 | Hypoproteinemia (HP:0003075) | 3.18672241 |
| 40 | IgA deficiency (HP:0002720) | 3.08242037 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02212534 |
| 42 | Vertebral arch anomaly (HP:0008438) | 2.90004665 |
| 43 | IgG deficiency (HP:0004315) | 2.88209246 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.88142511 |
| 45 | Abnormality of the fingertips (HP:0001211) | 2.86217148 |
| 46 | Emphysema (HP:0002097) | 2.84914226 |
| 47 | Obstructive lung disease (HP:0006536) | 2.81489653 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.81489653 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.78498249 |
| 50 | Periodontitis (HP:0000704) | 2.76266828 |
| 51 | Mitral stenosis (HP:0001718) | 2.74623284 |
| 52 | Pustule (HP:0200039) | 2.74049677 |
| 53 | Abnormality of the intervertebral disk (HP:0005108) | 2.70591751 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56131907 |
| 55 | Severe combined immunodeficiency (HP:0004430) | 2.55351300 |
| 56 | Combined immunodeficiency (HP:0005387) | 2.54477378 |
| 57 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.53908514 |
| 58 | T lymphocytopenia (HP:0005403) | 2.53155952 |
| 59 | Eosinophilia (HP:0001880) | 2.52715589 |
| 60 | * Skin rash (HP:0000988) | 2.50244594 |
| 61 | Gingivitis (HP:0000230) | 2.49093209 |
| 62 | * Chronic sinusitis (HP:0011109) | 2.48707840 |
| 63 | Abnormality of T cells (HP:0002843) | 2.48443567 |
| 64 | Increased IgE level (HP:0003212) | 2.47539203 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.45456367 |
| 66 | * Skin ulcer (HP:0200042) | 2.44938354 |
| 67 | Myositis (HP:0100614) | 2.43141468 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.41292941 |
| 69 | Bronchitis (HP:0012387) | 2.35882015 |
| 70 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.35363267 |
| 71 | Increased IgM level (HP:0003496) | 2.31594619 |
| 72 | Premature loss of primary teeth (HP:0006323) | 2.30190986 |
| 73 | Restrictive lung disease (HP:0002091) | 2.25547988 |
| 74 | Leukopenia (HP:0001882) | 2.25466649 |
| 75 | Flattened epiphyses (HP:0003071) | 2.23248550 |
| 76 | Chronic diarrhea (HP:0002028) | 2.21741863 |
| 77 | Granulocytopenia (HP:0001913) | 2.20637712 |
| 78 | * Recurrent otitis media (HP:0000403) | 2.20129435 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.18991743 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.18764010 |
| 81 | Optic neuritis (HP:0100653) | 2.18764010 |
| 82 | * Neutropenia (HP:0001875) | 2.17768116 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.17064664 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.16767009 |
| 85 | Lymphoma (HP:0002665) | 2.14230546 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.09027682 |
| 87 | Abnormality of male internal genitalia (HP:0000022) | 2.08099986 |
| 88 | Hypoplasia of the thymus (HP:0000778) | 2.06072083 |
| 89 | Hematochezia (HP:0002573) | 2.05729164 |
| 90 | Encephalitis (HP:0002383) | 2.05378397 |
| 91 | Urticaria (HP:0001025) | 2.04795376 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.04631696 |
| 93 | Viral hepatitis (HP:0006562) | 2.01735605 |
| 94 | Basal ganglia calcification (HP:0002135) | 2.00515443 |
| 95 | Leukocytosis (HP:0001974) | 1.98954932 |
| 96 | Orchitis (HP:0100796) | 1.97321360 |
| 97 | Pulmonary infiltrates (HP:0002113) | 1.93537981 |
| 98 | Prostate neoplasm (HP:0100787) | 1.88222071 |
| 99 | Chest pain (HP:0100749) | 1.88139593 |
| 100 | Disinhibition (HP:0000734) | 1.86265651 |
| 101 | Increased cerebral lipofuscin (HP:0011813) | 1.85287997 |
| 102 | Arthralgia (HP:0002829) | 1.85138382 |
| 103 | Petechiae (HP:0000967) | 1.85120081 |
| 104 | Xerostomia (HP:0000217) | 1.84481494 |
| 105 | Ulnar bowing (HP:0003031) | 1.83571263 |
| 106 | Acute lymphatic leukemia (HP:0006721) | 1.83087407 |
| 107 | Thrombocytosis (HP:0001894) | 1.80948404 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.79891981 |
| 109 | Abnormality of the thymus (HP:0000777) | 1.79289112 |
| 110 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.78741091 |
| 111 | Absent epiphyses (HP:0010577) | 1.78741091 |
| 112 | Hemoptysis (HP:0002105) | 1.75206931 |
| 113 | Pulmonary fibrosis (HP:0002206) | 1.74310660 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 1.70634522 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70634522 |
| 116 | Erythroderma (HP:0001019) | 1.70367825 |
| 117 | Polygenic inheritance (HP:0010982) | 1.67251477 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 1.66798892 |
| 119 | Stomach cancer (HP:0012126) | 1.61911518 |
| 120 | Type I transferrin isoform profile (HP:0003642) | 1.60053446 |
| 121 | 3-Methylglutaconic aciduria (HP:0003535) | 1.58816626 |
| 122 | Dry hair (HP:0011359) | 1.57070854 |
| 123 | Fatigue (HP:0012378) | 1.55066701 |
| 124 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.55052731 |
| 125 | Villous atrophy (HP:0011473) | 1.55052731 |
| 126 | Cutaneous photosensitivity (HP:0000992) | 1.53484432 |
| 127 | * Dehydration (HP:0001944) | 1.52963728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.67918146 |
| 2 | MAP4K1 | 4.11273384 |
| 3 | MAP3K14 | 3.72657946 |
| 4 | ERN1 | 3.25645427 |
| 5 | RIPK4 | 3.23123817 |
| 6 | EEF2K | 2.94102641 |
| 7 | CSF1R | 2.90463093 |
| 8 | BLK | 2.77775166 |
| 9 | VRK2 | 2.58114085 |
| 10 | TYK2 | 2.53231262 |
| 11 | * SYK | 2.28909391 |
| 12 | TBK1 | 2.25044671 |
| 13 | GRK6 | 2.15458798 |
| 14 | IKBKB | 2.12305095 |
| 15 | BTK | 1.97863503 |
| 16 | JAK1 | 1.93670862 |
| 17 | IRAK4 | 1.83530430 |
| 18 | MST4 | 1.79875890 |
| 19 | MAP3K13 | 1.77850560 |
| 20 | ZAK | 1.76692694 |
| 21 | SIK1 | 1.74103261 |
| 22 | STK4 | 1.69540199 |
| 23 | SIK2 | 1.69284584 |
| 24 | CDK19 | 1.67811516 |
| 25 | IRAK3 | 1.65477359 |
| 26 | CDK12 | 1.64649105 |
| 27 | JAK3 | 1.64318526 |
| 28 | TAF1 | 1.60923834 |
| 29 | LYN | 1.55650452 |
| 30 | SMG1 | 1.55416605 |
| 31 | CLK1 | 1.55249508 |
| 32 | STK10 | 1.51716621 |
| 33 | IKBKE | 1.50174241 |
| 34 | CHUK | 1.39256517 |
| 35 | KIT | 1.28745574 |
| 36 | TLK1 | 1.25705098 |
| 37 | PIM1 | 1.24735399 |
| 38 | FLT3 | 1.24622520 |
| 39 | NLK | 1.24205759 |
| 40 | PDK2 | 1.24001452 |
| 41 | GRK1 | 1.22849996 |
| 42 | FES | 1.20480121 |
| 43 | PIM2 | 1.18225673 |
| 44 | * HCK | 1.14791550 |
| 45 | VRK1 | 1.14052146 |
| 46 | LRRK2 | 1.08562725 |
| 47 | SIK3 | 1.08439257 |
| 48 | BMPR2 | 1.07849228 |
| 49 | NEK9 | 1.06274631 |
| 50 | FGFR3 | 1.03829127 |
| 51 | TEC | 1.03073464 |
| 52 | KDR | 1.01076478 |
| 53 | CCNB1 | 0.99909113 |
| 54 | CSK | 0.99359411 |
| 55 | LCK | 0.98838593 |
| 56 | ZAP70 | 0.96975684 |
| 57 | RPS6KA4 | 0.94402452 |
| 58 | ITK | 0.93671794 |
| 59 | TGFBR2 | 0.88784881 |
| 60 | FRK | 0.88746925 |
| 61 | NEK2 | 0.87779860 |
| 62 | PRKCQ | 0.87645730 |
| 63 | MAPKAPK5 | 0.87595422 |
| 64 | SCYL2 | 0.85714270 |
| 65 | DAPK1 | 0.85054378 |
| 66 | ACVR1B | 0.84533192 |
| 67 | EIF2AK2 | 0.84316585 |
| 68 | TRPM7 | 0.83492796 |
| 69 | EPHA2 | 0.82866581 |
| 70 | CDK4 | 0.81672832 |
| 71 | STK24 | 0.75608808 |
| 72 | MARK3 | 0.74967557 |
| 73 | MAPK12 | 0.73486139 |
| 74 | RPS6KB2 | 0.73377094 |
| 75 | PBK | 0.67917427 |
| 76 | BRD4 | 0.67342951 |
| 77 | IRAK1 | 0.65773928 |
| 78 | PRPF4B | 0.65233696 |
| 79 | TESK2 | 0.64108289 |
| 80 | MAPK11 | 0.62179276 |
| 81 | MATK | 0.60037965 |
| 82 | MAP3K11 | 0.59204955 |
| 83 | HIPK2 | 0.58650054 |
| 84 | FGFR4 | 0.58217286 |
| 85 | CDK8 | 0.57891015 |
| 86 | PRKCI | 0.57229143 |
| 87 | TXK | 0.55875310 |
| 88 | FGR | 0.55305881 |
| 89 | RPS6KB1 | 0.55110012 |
| 90 | NME2 | 0.54300080 |
| 91 | CDK6 | 0.52688598 |
| 92 | PRKCD | 0.52507296 |
| 93 | TAOK3 | 0.52015920 |
| 94 | ABL1 | 0.50469063 |
| 95 | MAPKAPK2 | 0.50060486 |
| 96 | EPHB1 | 0.49963694 |
| 97 | JAK2 | 0.49763340 |
| 98 | YES1 | 0.49228100 |
| 99 | TNK2 | 0.48665141 |
| 100 | PRKCH | 0.47867774 |
| 101 | BMPR1B | 0.47603575 |
| 102 | IRAK2 | 0.47258577 |
| 103 | MAP3K7 | 0.46686550 |
| 104 | ATR | 0.46243074 |
| 105 | MAPK7 | 0.43233827 |
| 106 | GRK5 | 0.42513439 |
| 107 | CDK7 | 0.42491405 |
| 108 | DYRK1B | 0.42100396 |
| 109 | OXSR1 | 0.40166463 |
| 110 | MAPK4 | 0.39767901 |
| 111 | MELK | 0.39211189 |
| 112 | EIF2AK3 | 0.39101169 |
| 113 | PKN2 | 0.37465237 |
| 114 | STK3 | 0.36966085 |
| 115 | DAPK3 | 0.34466940 |
| 116 | EGFR | 0.33514371 |
| 117 | NUAK1 | 0.33443238 |
| 118 | ARAF | 0.33427666 |
| 119 | RPS6KA5 | 0.31695582 |
| 120 | GRK7 | 0.31083313 |
| 121 | PDK1 | 0.30894815 |
| 122 | TRIB3 | 0.30278560 |
| 123 | MAP3K8 | 0.29978026 |
| 124 | ERBB3 | 0.28779438 |
| 125 | PTK6 | 0.28695848 |
| 126 | MAPKAPK3 | 0.27835666 |
| 127 | CDK9 | 0.27743535 |
| 128 | RPS6KA1 | 0.27701549 |
| 129 | PASK | 0.25163401 |
| 130 | FYN | 0.24987368 |
| 131 | PKN1 | 0.24400623 |
| 132 | MAP2K3 | 0.22658411 |
| 133 | PIK3CG | 0.21451344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 4.66688330 |
| 2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.76025343 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.27734551 |
| 4 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85456958 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61395650 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.40368054 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.33377032 |
| 8 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22454790 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13394397 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.04565133 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90145811 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89103294 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86468777 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85773821 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73387837 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.73030143 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.68636077 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67558309 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.61422301 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60013710 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.58848297 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58210184 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48733012 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44120166 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42046084 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.41327587 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41012565 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39644452 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38051635 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36583686 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33461056 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.32721546 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32431372 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27481093 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.26987000 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.21955939 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21372395 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17146808 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.16919777 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14291817 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13020001 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 1.11693656 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.10053119 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08964593 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08364883 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.06738130 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01405774 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00460918 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.99188105 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97193474 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96851735 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94649838 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93538146 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93310541 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92428408 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84701200 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.84333772 |
| 58 | Proteasome_Homo sapiens_hsa03050 | 0.83192236 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81867811 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80588086 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80298568 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79190670 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78332860 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75861546 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75781142 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71668914 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.69619851 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67924982 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67583094 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65735431 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65213132 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64694571 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.63875492 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.63658443 |
| 75 | DNA replication_Homo sapiens_hsa03030 | 0.63558721 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63532967 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62801812 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.60118500 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59944093 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.57628464 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55135207 |
| 82 | Mismatch repair_Homo sapiens_hsa03430 | 0.53978693 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52501158 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51888306 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49915656 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48723280 |
| 87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48204330 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48203180 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47996654 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.39940553 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38282429 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37141826 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36138820 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35141942 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.32044696 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31031782 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30706652 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30524804 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.30324093 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29975992 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29501930 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28550748 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.28115724 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.28014991 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27576324 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26721238 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24898627 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24708311 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24525586 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24068164 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23979801 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23737979 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23664037 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23280431 |
| 115 | Alcoholism_Homo sapiens_hsa05034 | 0.23062905 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.22756180 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16858571 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15665747 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.14742535 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.12978545 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.11690157 |
| 122 | Protein export_Homo sapiens_hsa03060 | 0.11203766 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10215390 |
| 124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.10128549 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.08304651 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.08146075 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.07782091 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.07556712 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04996975 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.03638637 |
| 131 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.03409220 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.02607432 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.01975257 |
| 134 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.00675715 |
| 135 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.00245867 |

